ED

EBEN DUROSS

REGENERON PHARMACEUTICALS, INC · TARRYTOWN, NY · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
2 agencies contacted
Activity
filings by quarter
Works on

Background

Career
TARRYTOWN, NY
2024 - present

Specific issues

Biodefense, FDA, national security, and privacy issues relating to biopharmaceutical manufacturers; tax and incentives; issues related to drug manufacturing and pricing; H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024; issues relating to pandemic preparedness and infectious disease education; issues relating to utilization management; issues relating to health care extenders; issues related to federal contracting relating to biopharmaceutical manufacturers
Health Issues · 2024 Q3
Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers
Medicare/Medicaid · 2024 Q3
Patent issues relating to biopharmaceutical manufacturers; intellectual property rights; issues relating to WTO TRIPS waivers
Copyright/Patent/Trademark · 2024 Q3
Biodefense, FDA, national security, and privacy issues relating to biopharmaceutical manufacturers; tax and incentives; issues related to drug manufacturing and pricing; H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024; issues relating to pandemic preparedness and infectious disease education; issues relating to step therapy; issues relating to health care extenders; issues related to federal contracting relating to biopharmaceutical manufacturers
Health Issues · 2024 Q2

Clients

$██,███ / qtrUnlock

Filing history

2024 Q3
REGENERON PHARMACEUTICALS, INC
Q3lda.gov →
2024 Q2
REGENERON PHARMACEUTICALS, INC
Q2lda.gov →
2024 Q1
REGENERON PHARMACEUTICALS, INC
Q1lda.gov →
Showing recent filings · full history on lda.gov